Chronic Cough Clinical Trial
Official title:
The Use of Capsaicin Challenge for Diagnosis, Monitoring and Follow-up of Chronic Cough.
The purpose of this study is to determine whether the capsaicin challenge can improve the diagnosis, treatment, monitoring and follow-up in patients with chronic cough.
Capsaicin is administrated in incremental concentrations with two inhalations of normal saline solution. Patients are instructed to exhale to functional residual capacity and than to inhale through the mouthpiece for 1 second (single breath inhalation). The number of coughs in the first 10 seconds after each inhalation is counted. C2; the concentration of which the patient responded by 2 coughs, C5;the concentration of which the patient responded by 5 coughs. The challenge ends at C5. ;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01432730 -
A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)
|
Phase 2 | |
Not yet recruiting |
NCT01413698 -
Cough Count Validation
|
N/A | |
Completed |
NCT03639727 -
Cough in Eastern and Central Finland
|
N/A | |
Completed |
NCT03696108 -
A Study of Gefapixant (MK-7264) in Japanese Adult Participants With Refractory or Unexplained Chronic Cough (MK-7264-038)
|
Phase 3 | |
Recruiting |
NCT03638063 -
ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
|
||
Recruiting |
NCT06376448 -
An Observational Study Using Novel Questionnaire to Characterize Cough Phenotypes in Patients With Chronic Cough
|
||
Completed |
NCT03172130 -
Sham CPAP vs. Straight CPAP for Chronic Cough
|
N/A | |
Recruiting |
NCT06286163 -
Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients
|
||
Completed |
NCT03622216 -
A Dose Escalation Study of Bradanicline in Refractory Chronic Cough
|
Phase 2 | |
Recruiting |
NCT05522699 -
Cough Suppressive Therapy in Patients With Chronic Cough
|
N/A | |
Completed |
NCT01297790 -
Cough Responses to Tussive Agents in Health and Disease
|
N/A | |
Completed |
NCT04193202 -
Efficacy and Safety of Gefapixant (MK-7264) in Adult Participants With Recent Onset Chronic Cough (MK-7264-043)
|
Phase 3 | |
Completed |
NCT01865422 -
French Linguistic and Metric Validations of Parent-proxy QOL Chronic Cough Specific Questionnaire (PC-QOL)
|
N/A | |
Completed |
NCT04525885 -
A Study of Gefapixant (MK-7264) in Adult Participants With Chronic Cough (MK-7264-030)-China Extension
|
Phase 3 | |
Completed |
NCT04193176 -
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)
|
Phase 3 | |
Recruiting |
NCT05362097 -
Analysis of the Reliability and Validity of the Chinese Version of CC-QoL
|
||
Recruiting |
NCT03787511 -
Chronic Cough and Small Fiber Neuropathy
|
N/A | |
Terminated |
NCT03864328 -
A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF
|
Phase 2 | |
Completed |
NCT05274516 -
A Trial of HRS-2261 in Healthy Subjects After Single and Multiple Oral Administration
|
Phase 1 | |
Enrolling by invitation |
NCT05689307 -
Validation Study With a Non-CE Marked Medical Device (MD)
|
N/A |